News
Few clinical trials are done in Africa: COVID-19 shows why this urgently needs to change
Few clinical trials are done in Africa: COVID-19 shows why this urgently needs to change
Monday, April 6, 2020
Clinical trials are the foundation of any new medicine. They allow scientists to test the efficacy and safety of a drug or therapy.
The African continent offers many of the best conditions for conducting clinical trials. It has a diverse population of potential patients, and many have not been previously exposed to any kind of pharmaceutical drugs. Importantly, a number of diseases – particularly those defined as neglected and tropical – are endemic to the developing world, which includes Africa.Read more ....
Related Articles
2018-03-29
African Academy of Sciences and the South African Medical Research Council tackle antimicrobial resistance in Africa
2023-08-07
Ten top health researchers named as fellowship recipients
2017-08-01
AAS announces appointment of new Executive Director
2020-06-19
Improving blood screening for safer transfusion practices
